Cosmos Health stock set for buybacks as insiders agree to lock-up
Published on 11/20/2026 at 22:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBuyback Plans And Insider Lock-Up
- Cosmos Health intends to resume open-market repurchases under its 5.0 million dollar program.
- Executives and board members agreed not to sell their shares for 12 months.
Cosmos Health stock is set for renewed shareholder measures after the company announced on November 19, 2026, that it intends to resume open-market repurchases and that its executives and board members will not sell their shares for 12 months.
The company said the repurchases will restart under a 5.0 million dollar program authorized by the board on June 26, 2026. About 3.85 million dollars remained available after the company had bought back 255,600 shares for approximately 1.15 million dollars. The company said the timing and amount of future purchases will depend on market conditions and that the program can be suspended or discontinued.
Management Links Buying And Ownership
The lock-up covers shares held by executive officers and board members. Cosmos Health said the combination of company repurchases and the insiders' commitment was intended to align management's interests with shareholders.
The announcement followed the company's report of record revenue of 53.59 million dollars for the first nine months of 2026. That release said revenue rose 17.6 percent from the year-earlier period, while third-quarter gross margin improved sequentially to 12.6 percent. Adjusted EBITDA remained negative at a loss of 0.93 million dollars.
The buyback plan is an intention rather than a guarantee that purchases will occur at a specific pace or price. For investors, the remaining authorization and the 12-month insider restriction are the main capital-allocation details in the announcement.
The Detroit Free Press carried the company release distributed through ACCESS Newswire.
Cosmos Health Inc.
- Stock symbol: COSM
- Primary exchange: NASDAQ
- Share repurchase program: 5.0 million dollars authorized; approximately 3.85 million dollars remaining
- Insider lock-up: 12 months
The NASDAQ Composite market environment provides the broader setting for U.S.-listed healthcare stocks.
